Kyoshi Mirai

Kyoso Mirai Pharma Co., Ltd. is a Japanese pharmaceutical company and a core subsidiary of Toho Holdings Co., Ltd. It serves as the manufacturing and marketing arm for the Kyoso Mirai Group, one of Japan's largest pharmaceutical wholesaling and healthcare service networks. The company specializes in the production and distribution of a wide range of generic pharmaceuticals, covering therapeutic areas such as cardiovascular disease, metabolic disorders, and inflammatory conditions. Kyoso Mirai Pharma was established in 2013 through the rebranding of Yell Pharmaceutical to align with the group's "Kyoso Mirai" (Co-creation Future) philosophy. Leveraging the extensive distribution infrastructure of Toho Holdings, the company ensures a stable and efficient supply of high-quality generic medicines to medical institutions and pharmacies across Japan.